{"id":{"repo_id":"athens","oai_identifier":"oai:lib.uoa.gr:uoadl:3335794"},"canonical_url":"https://search.ndltd.org/etd/athens/oai:lib.uoa.gr:uoadl:3335794","repository":{"repo_id":"athens","name":"National and Kapodistrian University of Athens","base_url":"https://pergamos.lib.uoa.gr/uoa/dl/frontend/oaipmh"},"display":{"title":"Θέση του κυτταρομεγαλοιού σε βαρέως πάσχοντες ασθενείς απο SARS-Cov-2","abstract":"Οι φαρμακοθεραπείες για τον CMV μπορεί να διαδραματίσουν ρόλο στην πρόληψη ή τον μετριασμό της αναζωπύρωσης του CMV σε ασθενείς με λοίμωξη COVID-19. H τρέχουσα κατανόηση της αναζωπύρωσης του CMV στο πλαίσιο της λοίμωξης COVID-19 είναι περιορισμένη και απαιτείται περαιτέρω έρευνα. Περαιτέρω διερεύνηση της σχέσης μεταξύ της αναζωπύρωσης του CMV και της σοβαρότητας της λοίμωξης COVID-19.","abstract_html":"Οι φαρμακοθεραπείες για τον CMV μπορεί να διαδραματίσουν ρόλο στην πρόληψη ή τον μετριασμό της αναζωπύρωσης του CMV σε ασθενείς με λοίμωξη COVID-19. H τρέχουσα κατανόηση της αναζωπύρωσης του CMV στο πλαίσιο της λοίμωξης COVID-19 είναι περιορισμένη και απαιτείται περαιτέρω έρευνα. Περαιτέρω διερεύνηση της σχέσης μεταξύ της αναζωπύρωσης του CMV και της σοβαρότητας της λοίμωξης COVID-19.","abstract_has_math":false,"creators":["Μουστακά Βασιλική","Moustaka Vasiliki"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023","date_published":"2023","updated_at":"2026-11-19T06:22:50Z","subjects":["Επιστήμες Υγείας","Health Sciences"],"languages":["Ελληνικά","Greek"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["uoadl:3335794"],"render_values":[{"text":"uoadl:3335794","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://pergamos.lib.uoa.gr/uoa/dl/object/3335794","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://pergamos.lib.uoa.gr/uoa/dl/object/3335794","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://pergamos.lib.uoa.gr/uoa/dl/frontend/oaipmh?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Alib.uoa.gr%3Auoadl%3A3335794","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Μουστακά Βασιλική","Moustaka Vasiliki"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023"]},{"key":"dc:type","label":"Dc Type","values":["born_digital_postgraduate_thesis","Διπλωματική Εργασία","Postgraduate Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Επιστήμες Υγείας","Health Sciences"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["Ελληνικά","Greek"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["uoadl:3335794","https://pergamos.lib.uoa.gr/uoa/dl/object/3335794"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Οι φαρμακοθεραπείες για τον CMV μπορεί να διαδραματίσουν ρόλο στην πρόληψη ή τον μετριασμό της αναζωπύρωσης του CMV σε ασθενείς με λοίμωξη COVID-19. H τρέχουσα κατανόηση της αναζωπύρωσης του CMV στο πλαίσιο της λοίμωξης COVID-19 είναι περιορισμένη και απαιτείται περαιτέρω έρευνα. Περαιτέρω διερεύνηση της σχέσης μεταξύ της αναζωπύρωσης του CMV και της σοβαρότητας της λοίμωξης COVID-19.","CMV pharmacotherapies may have a role in preventing or mitigating CMV reactivation in COVID-19 patients, particularly those who are at high risk for reactivation, such as CMV-seropositive individuals and immunocompromised patients. However, the current understanding of CMV reactivation in the context of COVID-19 is limited, and further research is needed to establish the efficacy and safety of CMV pharmacotherapy in this population. Future interventional trials could help determine whether CMV pharmacotherapies can improve clinical outcomes in COVID-19 patients at high risk for CMV reactivation. Finally, further investigation into the relationship between CMV reactivation and COVID-19 severity may provide valuable insights into the possible benefits of CMV-specific suppression and/or therapy in managing the disease and improving patient outcomes."]},{"key":"dc:title","label":"Title","values":["Θέση του κυτταρομεγαλοιού σε βαρέως πάσχοντες ασθενείς απο SARS-Cov-2"]}]}],"canonical_facts":{"dc:creator":["Μουστακά Βασιλική","Moustaka Vasiliki"],"dc:date":["2023"],"dc:description":["Οι φαρμακοθεραπείες για τον CMV μπορεί να διαδραματίσουν ρόλο στην πρόληψη ή τον μετριασμό της αναζωπύρωσης του CMV σε ασθενείς με λοίμωξη COVID-19. H τρέχουσα κατανόηση της αναζωπύρωσης του CMV στο πλαίσιο της λοίμωξης COVID-19 είναι περιορισμένη και απαιτείται περαιτέρω έρευνα. Περαιτέρω διερεύνηση της σχέσης μεταξύ της αναζωπύρωσης του CMV και της σοβαρότητας της λοίμωξης COVID-19.","CMV pharmacotherapies may have a role in preventing or mitigating CMV reactivation in COVID-19 patients, particularly those who are at high risk for reactivation, such as CMV-seropositive individuals and immunocompromised patients. However, the current understanding of CMV reactivation in the context of COVID-19 is limited, and further research is needed to establish the efficacy and safety of CMV pharmacotherapy in this population. Future interventional trials could help determine whether CMV pharmacotherapies can improve clinical outcomes in COVID-19 patients at high risk for CMV reactivation. Finally, further investigation into the relationship between CMV reactivation and COVID-19 severity may provide valuable insights into the possible benefits of CMV-specific suppression and/or therapy in managing the disease and improving patient outcomes."],"dc:identifier":["uoadl:3335794","https://pergamos.lib.uoa.gr/uoa/dl/object/3335794"],"dc:language":["Ελληνικά","Greek"],"dc:subject":["Επιστήμες Υγείας","Health Sciences"],"dc:title":["Θέση του κυτταρομεγαλοιού σε βαρέως πάσχοντες ασθενείς απο SARS-Cov-2"],"dc:type":["born_digital_postgraduate_thesis","Διπλωματική Εργασία","Postgraduate Thesis"]},"updated_at":"2026-11-19T06:22:50Z"}